Greg Lynch

Greg Lynch is a seasoned professional with extensive experience in engineering and validation consulting across various industries, including pharmaceuticals, biotechnology, and medical devices. Currently serving as a Senior Consultant in Aseptic Manufacturing at Heron Therapeutics, Inc., Greg assists with the scale-up and regulatory submissions for the combination product ZYNRELEF®. As the President and Senior Consultant at ECVS, Inc., Greg provides engineering and validation services while also contributing to microenterprise development through involvement on the Board of Directors at Heartbeat For Africa Foundation. Previous roles include consulting positions at Meridian Medical Technologies, Lachman Consultant Services, and Allergan, where Greg specialized in quality assurance, process engineering, and remediation efforts. Greg holds a B.S. in Chemical Engineering from Colorado State University.